Chronic pain affects roughly 1 in 5 Canadian adults at any given time. For most people, standard pain management approaches—physical therapy, exercise, anti-inflammatories, and other systemic medications—work reasonably well. For a smaller but significant group, standard approaches don’t provide enough relief, cause intolerable side effects, or aren’t appropriate for the patient’s specific situation.

This is the group for whom compounded pain medications are sometimes considered. This page explains where compounding fits, what it does well, and what it doesn’t do—so you can have an informed conversation with your prescriber about whether it makes sense for you.

What Compounded Pain Medications Are

Compounded pain medications are custom-prepared formulations made by a compounding pharmacy from raw, pharmaceutical-grade ingredients. The most common types:

• Topical pain creams combining multiple actives in a single application for localized pain relief
• Low-dose naltrexone (LDN)—naltrexone at much lower doses than its standard 50 mg use—prepared as compounded capsules
• Custom-strength oral medications for patients whose prescribed doses don’t exist commercially
• Combination capsules that bring multiple compatible pain medications into a single dose
• Specialty topical preparations for specific conditions or skin sensitivities

Each of these has different properties, evidence bases, and appropriate uses.

Where Compounding Fits Among Pain Treatment Options

For chronic pain, treatment approaches generally include several categories, often used in combination:

Non-Pharmacological Approaches

• Physical therapy and structured exercise
• Cognitive behavioral therapy and chronic pain self-management programs
• Sleep hygiene improvements (poor sleep significantly amplifies pain)
• Stress management and mindfulness-based approaches
• Weight management when relevant for joint or musculoskeletal pain
• Acupuncture, massage, and other complementary approaches with varying evidence

These foundations matter even when medications are part of the plan. Compounded pain medications work better in patients who are also addressing the non-pharmacological components.

First-Line Pharmacological Options

• Acetaminophen for many types of mild-to-moderate pain
• NSAIDs (ibuprofen, naproxen, diclofenac) for inflammatory pain, when not contraindicated
• Topical NSAIDs (commercial products like diclofenac gel) for localized inflammatory pain
• Topical lidocaine patches or commercial topical anesthetics

Many patients with chronic pain do well with these approaches and never need compounded options.

Second-Line Options for Specific Pain Types

• For neuropathic pain: gabapentin, pregabalin, duloxetine, tricyclic antidepressants (amitriptyline, nortriptyline)
• For inflammatory pain: stronger anti-inflammatories, sometimes corticosteroids in specific situations
• For specific conditions: condition-targeted therapies (DMARDs for rheumatoid arthritis, biologics for certain inflammatory conditions, triptans for migraines)

Where Compounded Medications Are Sometimes Considered

Compounded pain medications are sometimes considered when:

• First and second-line options have been tried and not provided adequate relief
• Side effects from systemic medications limit their use
• The patient takes multiple medications and is sensitive to additional systemic load
• The pain is localized and might respond to high concentrations of medication delivered topically
• The patient has specific sensitivities that make commercial preparations unsuitable
• A specific compounded formulation (LDN, for example) is being considered for an off-label indication where some evidence supports its use

Where Compounded Medications Are Less Appropriate

• Acute pain that is expected to resolve—standard medications usually work and are simpler
• Pain where commercial alternatives are clinically equivalent and adequately effective
• Cases where the underlying condition needs specific treatment (e.g., compression fracture needing orthopedic management) that compounding doesn’t address
• Severe pain requiring opioid management—compounding doesn’t replace this when opioids are clinically indicated

What Compounding Does Well

Localized Delivery

Topical pain creams allow medication concentrations at the site of pain that wouldn’t be achievable safely through oral administration. For localized pain (a specific arthritic joint, peripheral neuropathy in feet and hands, post-surgical pain at a specific site), this can mean meaningful local effect with much lower systemic absorption.

Combinations Not Available Commercially

Combining multiple actives in a single topical preparation is something only compounding can offer. A cream containing ketamine, gabapentin, amitriptyline, and lidocaine, for example, addresses several mechanisms of pain in one application—useful for some patients with complex pain, where each component might individually be inadequate.

Customization for Sensitivities

Patients who react to specific ingredients in commercial products (preservatives, dyes, specific bases) can have compounded preparations made without those triggers.

Custom Doses for Specific Patients

For patients whose prescribed dose doesn’t exist commercially—for example, someone titrating slowly off a medication, or a patient who needs a non-standard strength—compounding allows precise dosing.

Off-Label Specialty Formulations

Some medications used off-label in pain management aren’t commercially available at the doses needed. Low-dose naltrexone is the prominent example—naltrexone at 1.5–4.5 mg isn’t a commercial product, but it can be compounded for patients whose prescribers determine LDN is appropriate.

What Compounding Doesn’t Do

It Doesn’t Make Strong Evidence Out of Weak Evidence

The fact that a compound can be prepared doesn’t mean it works. Evidence for compounded pain medications varies considerably:

• Some formulations have meaningful evidence (LDN for fibromyalgia, for instance, has multiple small RCTs and observational studies)
• Some have moderate evidence (topical NSAIDs and lidocaine for localized pain)
• Some have limited evidence beyond clinical experience (specific multimodal pain cream combinations)
• Some have very limited evidence (novel combinations or unusual indications)

Patients should ask their prescriber what evidence supports the specific compounded medication being considered.

It Doesn’t Replace a Comprehensive Pain Management Plan

Compounded pain medications work best as part of a broader plan that addresses sleep, exercise, stress, mood, lifestyle factors, and the underlying condition causing pain. Compounded medications alone, without these other components, often disappoint.

It Doesn’t Bypass Risk-Benefit Considerations

Compounded medications still have side effects. Topical creams can cause skin irritation. LDN can cause sleep changes and side effects. Combining medications can introduce drug interactions. Just because a medication is custom-prepared doesn’t make it risk-free.

It Doesn’t Provide Quick Relief in Most Cases

Compounded pain medications—particularly LDN and many topical formulations—often take weeks to show effect. Patients expecting immediate relief sometimes give up before the medication has had time to work.

Realistic Expectations

Honest framing of what compounded pain medications typically achieve for the patients who benefit:

• Partial improvement, not complete relief. Most patients who respond to compounded pain medications experience meaningful but not complete improvement—reduction in pain intensity, fewer flare-ups, better sleep, better function—but not absence of pain.
• Gradual response. Effects often build over 4–12 weeks rather than days.
• Not everyone responds. A meaningful fraction of patients try compounded pain medications without benefit. This is true for most pain treatments; compounding is no exception.
• Best as part of multimodal management. Patients combining compounded medications with physical therapy, exercise, sleep work, and other components tend to do better than those relying on medications alone.

Working with Your Prescriber

If you’re considering compounded pain medications, useful questions for your prescriber:

• What evidence supports this specific formulation for my type of pain?
• What are the realistic expected outcomes?
• How will we know if it’s working—and over what timeframe?
• What other components should be part of my pain management plan?
• What are the alternatives, and why are we considering compounding rather than those?
• What side effects or interactions should I watch for?
• How long would I expect to be on this medication?

What to Expect Practically

If your prescriber writes a compounded pain prescription:

Time to Prepare

Standard turnaround for compounded pain preparations is typically 1–3 business days. Complex multimodal creams may take 2–3 days; simple capsules can be ready faster.

Cost and Insurance

Compounded pain medications may or may not be covered by your extended health plan. Coverage depends on the specific ingredients and your individual plan. We provide upfront pricing before any compound is prepared.

Counselling at Pickup

When you pick up your medication, our pharmacist explains how to use it, what to expect, what side effects to watch for, and when to follow up with your prescriber. Application technique matters significantly for topical creams—we walk through this.

Follow-Up

Your prescriber typically reassesses you at 4–12 weeks to evaluate response. Based on what’s working and what isn’t, the formulation may be adjusted. Compounded pain medications are often refined over time as you and your prescriber learn what fits your situation.

Where to Learn More

For specific compound types, see our pages on:

• Low-dose naltrexone (LDN) for pain and inflammation
• Compounded topical pain creams
• Neuropathic pain and compounded options
• Arthritis and musculoskeletal pain

For broader chronic pain education, your healthcare team or programs like the Pain BC Society (painbc.ca) provide resources for patients living with chronic pain.